Business Context and Reporting Period
This Form 6-K filing by Novo Nordisk A/S, dated March 2, 2026, reports on the completion of the election of employee representatives to the Board of Directors. Novo Nordisk is a leading global healthcare company headquartered in Denmark, employing approximately 68,800 people across 80 countries and marketing products in around 170 countries. The company focuses on defeating serious chronic diseases, with a heritage in diabetes care.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance announcement and does not contain financial performance data.
Material Changes
The primary material change reported is the composition of the Board of Directors following the employee election:
- Newly Elected Representatives: Semsi Kilic Madsen and Désirée Jantzen Asgreen.
- Re-elected Representatives: Mette Bøjer Jensen and Elisabeth Dahl Christensen.
- Resignations: Current board members Liselotte Hyveled and Tanja Villumsen will resign as they did not run for re-election as employee representatives.
- Substitutes Elected: Trine Hartvig Kristiansen, Tamara Schmidt, Tanja Villumsen, and Hassan Kassem.
The newly elected representatives will join the Board following the annual general meeting on March 26, 2026.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on strategy, risks, contingencies, or unusual items. The document strictly addresses the statutory requirement under the Danish Companies Act for employee representation on the Board.
Key Facts for Investor Verification
- Verify the effective date of the new board members joining the Board (post-March 26, 2026 AGM).
- Confirm the resignation of Liselotte Hyveled and Tanja Villumsen coincides with the AGM.
- Note that employee-elected members serve a four-year term with rights equal to shareholder-elected members.
- Check subsequent filings for the next scheduled financial results, as this 6-K contains no financial data.